Considering that gene amplification is a tumor-specific event during malignant transformation, and that SOX2 locus is subjected to this alteration in other tumors, namely of the lung and esophagus [17], we hypothesized that SOX2 amplification could explain its expression and heterogeneity, both within and among gastric tumors. The gene discussed is SOX2; the disease is neoplasm.